Highlights
Maternal mortality due to severe peripartum infections is high, especially in resource-limited settings like India.
This position statement is meant to provide insights into bedside management of severe peripartum infections and for decision-making to shift the patients to higher centres with clinical worsening.
Methodology
The ISCCM convened a meeting on 16 July 2023 to identify the writing group members and set the objectives for the position statement. The working group was formed by involving ten Critical Care Physicians with a special interest in Obstetric Critical Care from across the country. The group identified the following areas concerning peripartum infections, keeping in mind the issues relevant to the Indian subcontinent, where a review of the literature was needed and the problem areas that need to be addressed.
Peripartum dengue infection.
Peripartum malaria.
Peripartum scrub typhus.
Peripartum leptospirosis.
Pulmonary and extrapulmonary tuberculosis.
Viral pneumonias.
Peripartum sepsis
MDR and XDR infections.
The writing group had a round table meeting and specific questions about each of the problems were identified by the group.
The questions identified to be answered for each of the areas are listed in the table below.
Each member of the writing group was allocated specific areas and questions to be answered in 2 months’ time period. The methodology for research and review of literature was defined. The search terms for each of the problem areas were set by the respective member answering the relevant questions. Multiple zoom meetings were convened in September to November 2023 to review the literature and discuss each of the recommendations among the core group. Thereafter a final draft including answers to each defined problem was made with specific recommendations. The final round was conducted through an email by circulating the draft recommendations to the other members of the writing group and a final version was arrived at by 1st December 2023.
This writing group, in discussion with the ISCCM leadership, chose not to draft a position statement on puerperal sepsis, since established guidelines on the topic already exist.
Introduction
Peripartum infections pose significant risks to pregnant women and their unborn children. The incidence of infections in pregnancy has been steadily increasing globally. The literature available is scarce, making it crucial to address the specific challenges faced by the affected pregnant women. This Indian Society of Critical Care Medicine (ISCCM) position statement aims at providing a universal standard of care based on the available evidence which can be followed by Critical Care Physicians involved in the care of sick pregnant women due to peripartum infections and ensure the well-being of both the mothers and the infants.
Peripartum Dengue Infection
Dengue fever (DF) is a mosquito-borne viral infection, endemic in the tropical and subtropical regions and thereby posing a significant public health challenge.
Pregnant women have a high vulnerability to severe dengue infections and can transmit the virus to their infants before or during delivery. 1 Previous research indicates that dengue during pregnancy heightens the risk of maternal complications such as hemorrhage, preterm labor, reduced amniotic fluid (oligohydramnios), fetal death, and direct transmission of infection from the mother to the neonate, causing neonatal thrombocytopenia requiring platelet transfusion. 2 , 3 The symptomatology of dengue in pregnant women can overlap with the clinical presentation in hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome. Therefore, serological tests are essential to differentiate between these conditions. 4 Routinely, all three serological assays for the detection of specific antibodies including dengue IgM/IgG and NS1 antigen should be done since they may be detected during different phases of the disease, which will aid in reducing errors.
We cannot recommend any specific severity marker for dengue infection in pregnancy.
We suggest using the same severity criteria as used for non-pregnant adults.
Pregnant women infected with the dengue infection face increased risks of severe complications, including hemorrhagic fever and organ failure. Moreover, vertical transmission of the virus to the fetus can occur from the mother, to the fetus leading to adverse pregnancy outcomes such as fetal developmental abnormalities and preterm low birth weight babies. There are no separate severity assessment criteria for dengue available that are specific to peripartum females and therefore we suggest the same severity criteria as used for adults can be used. 5
We cannot recommend any specific fluid resuscitation protocol for dengue infection in pregnancy.
We suggest using the same fluid resuscitation protocol as used for non-pregnant adults.
Fluid resuscitation is a critical aspect of managing severe dengue during pregnancy, as it helps in maintaining adequate organ perfusion and preventing complications associated with plasma leakage. The World Health Organization (WHO) provides guidelines for fluid resuscitation in severe dengue, which are generally applicable to pregnant women as well. 5 The key points to consider when administering fluid resuscitation to pregnant women with severe dengue are:
Assessment of fluid status: Evaluate the patient's clinical condition including vital signs, urine output, and lab investigations like hematocrit level, and platelet counts to assess the severity of plasma leakage and determine the likely need for fluid resuscitation.
Type of fluid: Use isotonic, balanced salt solutions, or Ringer's lactate as the primary fluid for resuscitation. Avoid the use of hypotonic solutions, such as half-normal saline, as they can exacerbate fluid shifts and worsen tissue edema.
Fluid rate: Administer fluids cautiously and adjust the fluid administration rate based on the patient's response. The goal is to maintain an adequate perfusion pressure while avoiding fluid overload, which can lead to respiratory distress and other complications. Start with a moderate rate, (e.g., 5–7 mL/kg/hour) and adjust according to the patient's clinical response.
Monitoring: Monitor the patient closely for signs of fluid overload, such as increased respiratory rate, crackles in the lungs, and decreasing oxygen saturation. Urine output, hematocrit levels, and platelet counts should be monitored regularly to assess the response to fluid resuscitation.
Hematocrit and platelet count trends: Rising hematocrit levels and falling platelet counts are indicators of plasma leakage. If hematocrit levels rise significantly or platelet counts drop to a critical level, consider increasing the fluid rate cautiously to maintain organ perfusion. In patients who do not respond to fluid boluses of isotonic saline, we can consider administering colloids such as albumin for refractory shock on an individual basis.
Transfusions: Transfuse packed red blood cells if there is evidence of severe bleeding leading to hemodynamic instability. Platelet transfusions may be considered if severe thrombocytopenia (<20,000/mm³) is present, especially in the context of bleeding.
Avoid overhydration: Be vigilant to avoid overhydration, especially in pregnant women, as excessive fluids can lead to pulmonary edema and compromise respiratory function.
Continuous monitoring: Continuously monitor the patient's clinical status, laboratory values, and fluid balance. Adjust fluid administration rates promptly based on the patient's response and evolving clinical condition.
It is crucial to tailor the fluid resuscitation strategy based on the individual patient's condition, considering the unique physiological changes and requirements associated with pregnancy.
We cannot make any specific recommendation for transfusion of blood products for dengue-complicating pregnancy.
We suggest the standard recommendations for platelet counts during neuraxial anesthesia be applicable for dengue-complicating pregnancy.
Indications for blood product support in severe dengue in pregnancy typically revolve around managing complications related to severe bleeding and low platelet counts. The common indications for blood product support in pregnant females with severe dengue are:
Severe Thrombocytopenia: Platelet counts dropping below a certain threshold, often 20000/mm 3 , can necessitate platelet transfusions, especially if there is evidence of bleeding or a high risk of bleeding (e.g., invasive procedures).
Active or Profuse Bleeding: Urgent packed red blood cells (PRBCs) transfusion may be required if there is active or profuse bleeding, to restore blood volume and prevent hemorrhagic shock.
Hemorrhagic Shock: In cases where severe bleeding leads to hemodynamic instability and shock, transfusion of PRBCs is essential to maintain tissue perfusion and oxygenation.
Platelet Dysfunction: Platelet dysfunction, indicated by prolonged bleeding time and abnormal platelet function tests, may require platelet transfusions to improve hemostasis.
Severe Anemia: If severe dengue-related anemia is present, transfusion of PRBCs might be necessary to increase hemoglobin levels and improve oxygen-carrying capacity.
Disseminated Intravascular Coagulation (DIC): Pregnant women with severe dengue may develop DIC, characterized by widespread activation of clotting factors and excessive bleeding. Blood products including single donor platelets and clotting factor concentrates, might be needed to manage this complication.
Bleeding During Delivery: If a pregnant woman with severe dengue experiences significant bleeding during delivery, blood product support, including PRBCs and platelets, may be required to manage the bleeding and stabilize the patient.
Surgical Procedures: If surgical interventions are necessary, such as caesarean section or other obstetric procedures, blood product support may be required to manage intraoperative and postoperative bleeding.
Patient's Clinical Status: The overall clinical condition, including vital signs, lab results, and response to other treatments should be the basis for the decision to administer blood products. Close monitoring is essential to assess the need for blood product support.
We cannot recommend any specific perioperative plan for a pregnant woman with Dengue infection.
We suggest platelet transfusions to be administered closer to the surgery.
We suggest general anesthesia be preferred over regional anesthesia.
The evidence for anesthesia management in pregnant dengue patients is mainly from isolated case reports, with no specific recommendations or guidelines available in the literature. 6 , 7 The risk of hemorrhage is the key concern in these patients, so platelet transfusions should be planned closer to the surgical time so as to minimize perioperative bleeding. 8 Considering the potential for spinal hematoma, general anesthesia is considered a safer choice compared to regional anesthesia. 9 No specific cutoff value for platelets has been recommended prior to delivery or caesarean section but as per the consensus, a threshold of 50,000 can be accepted as for other surgeries.
We cannot recommend any specific early warning signs and criteria for transport for a pregnant woman with dengue infection
We suggest using the same early warning signs and criteria for referral of a pregnant female with Dengue infection as used for non-pregnant adults.
The warning signs that should alert us against a possible worse prognosis in a diagnosed dengue pregnant patient include:
Abdominal pain or tenderness.
Persistent vomiting.
Clinical fluid accumulation.
Mucosal bleed.
Lethargy or restlessness.
Liver enlargement >2 cm.
Laboratory finding of increasing Hct concurrent with a rapid decrease in platelet count.
Transporting a pregnant woman with dengue infection requires specific considerations due to the potential complications associated with the disease including:
If the pregnant woman is experiencing severe symptoms such as persistent vomiting, severe abdominal pain, bleeding, or difficulty in breathing, immediate medical attention and transport to a hospital are necessary.
Medical evaluation: A healthcare professional should assess the pregnant woman's condition to determine the severity of the infection and the need for hospitalization.
Hydration: If the pregnant woman is unable to drink fluids or is showing signs of severe dehydration (such as dizziness, rapid heartbeat, or sunken eyes), intravenous fluid administration might be necessary during transport.
Platelet count: Dengue fever can lead to a decrease in platelet count, which can cause bleeding. If the platelet count drops significantly, hospitalization might be necessary for close monitoring and transfusion if required.
Pregnancy complications: Pregnant women with dengue fever are at an increased risk of complications, including preterm delivery and low birth weight babies. Close monitoring and appropriate medical care are crucial to ensure the fetal well-being. Transport to an equipped hospital is mandated for cases with high risk.
Availability of medical facilities: If the pregnant woman is in an area where medical resources are limited, it might be advisable to transport her to a location with better medical facilities, especially if she is experiencing severe symptoms.